Results 171 to 180 of about 22,658,854 (391)

Nanocarrier‐Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy

open access: yesAdvanced Healthcare Materials, EarlyView.
This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail   +3 more
wiley   +1 more source

The contribution of interleukin-2 to effective wound healing

open access: yesExperimental biology and medicine, 2017
K. M. Doersch   +2 more
semanticscholar   +1 more source

Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. [PDF]

open access: bronze, 1981
David Wofsy   +5 more
openalex   +1 more source

Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision

open access: yesAdvanced Healthcare Materials, EarlyView.
Advancements in ART improve HIV‐1 patient outcomes but are unable to eliminate latent viral DNA. To address this, CXCR4‐targeted lipid nanoparticles (T‐LNPs) for delivering CRISPR‐Cas9 to excise HIV‐1 DNA in infected cells are developed. These T‐LNPs achieve ≈60% HIV‐1 DNA excision efficacy in blood and splenic tissue, demonstrating promise for ...
Sudipta Panja   +6 more
wiley   +1 more source

Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression

open access: yesHYPERTENSION, 2016
Huan Wang   +12 more
semanticscholar   +1 more source

Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. [PDF]

open access: bronze, 1986
John C. Reed   +5 more
openalex   +1 more source

Interferon Alfa in the treatment of B-cell chronic lymphocytic leukemia [PDF]

open access: yes, 1994
Adolf, D.   +10 more
core   +1 more source

Safety Evaluation of Repeated Application of Polymeric Microarray Patches in Miniature Pigs

open access: yesAdvanced Healthcare Materials, EarlyView.
This study demonstrates the safety of repeated application of three types of microarray patches (MAPs), hydrogelforming, dissolving, and implantable, over four weeks in miniature pigs. No adverse skin or systemic effects were observed, supporting the clinical potential of MAPs as safe and effective drug delivery platforms.
Qonita Kurnia Anjani   +4 more
wiley   +1 more source

Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia

open access: bronze, 1987
M Maeda   +9 more
openalex   +1 more source

Interleukin-2 [PDF]

open access: yes, 2002
James W. Mier, Michael B. Atkins
openaire   +1 more source

Home - About - Disclaimer - Privacy